NABRIVA THERAPEUTICS PLC's ticker is and the CUSIP is G63637903. A total of 3 filers reported holding NABRIVA THERAPEUTICS PLC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $38,000 | -75.5% | 91,700 | -64.7% | 0.00% | – |
| Q4 2021 | $155,000 | -57.8% | 259,600 | -8.2% | 0.00% | – |
| Q3 2021 | $367,000 | -3.7% | 282,900 | +0.1% | 0.00% | – |
| Q2 2021 | $381,000 | +2.7% | 282,700 | +12531.8% | 0.00% | -100.0% |
| Q1 2021 | $371,000 | +107.3% | 2,238 | +200.8% | 0.00% | – |
| Q4 2020 | $179,000 | – | 744 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 44,800 | $27,000 | 0.00% |
| SIMPLEX TRADING, LLC | 259,600 | $155,000 | 0.00% |